“The Vitamin B12 Receptor CD320 Is a Key Metabolic Dependency and Prognostic Biomarker in Hepatocellular Carcinoma”. Highlights in Science, Engineering and Technology 162 (April 17, 2026): 227–240. Accessed September 15, 2026. https://datahset.net/index.php/ojs/article/view/41.